Grade as a prognostic factor in oral squamous cell carcinoma: A population-based analysis of the data

Laryngoscope

Volumn 124, Issue 3, 2014, Pages 688-694

  Thomas, Brian ^a   Stedman, Margaret ^d   Davies, Louise ^a,b,c  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^c VA MEDICAL CENTER   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

and end results database; grade; Oral cavity; pathology; prognosis; SEER; squamous cell carcinoma; survival; survival epidemiology

Indexed keywords

AND END RESULTS DATABASE; GRADE; ORAL CAVITY; PATHOLOGY; PROGNOSIS; SEER; SQUAMOUS CELL CARCINOMA; SURVIVAL; SURVIVAL EPIDEMIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; CAUSE OF DEATH; COHORT STUDIES; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; SEER PROGRAM; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84894447239     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24357     Document Type: Conference Paper

References (29)

1. Soudry E, Preis M, Hod R, et al. Squamous cell carcinoma of the oral tongue in patients over 75 years old. Aging Clin Exp Res 2011; 23: 231-235.
2. Rades D, Seibold ND, Gebhard MP, Noack F, Schild SE, Thorns C,. Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN). Strahlenther Onkol 2011; 187: 626-632.
3. Peter F, Wittekindt C, Finkensieper M, Kiehntopf M, Guntinas-Lichius O,. Prognostic impact of pretherapeutic laboratory values in head and neck cancer patients. J Cancer Res Clin Oncol. 2013; 139: 171-178.
4. Arduino PG, Carrozzo M, Chiecchio A, et al. Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases. J Oral Maxillofac Surg 2008; 66: 1570-1579.
5. Weijers M, Snow GB, Bezemer PD, Van der Waal I,. Malignancy grading is no better than conventional histopathological grading in small squamous cell carcinoma of tongue and floor of mouth: retrospective study in 128 patients. J Oral Pathol Med 2009; 38: 343-347.
6. Roland N, Caslin A, Nash J, Stell P,. Value of grading squamous cell carcinoma of the head and neck. Head Neck 1992; 14: 224-229.
7. Piffko J, Bankfalvi A, Ofner D, et al. Prognostic value of histobiological factors (malignancy grading and AgNOR content) assessed at the invasive tumour front of oral squamous cell carcinomas. Br J Cancer 1997; 75: 1543-1546.
8. Brandwein-Gensler M, Teixeira MS, Lewis CM, et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 2005; 29: 167-178.
9. Lindenblatt RDCR, Martinez GL, Silva LE, Faria PS, Camisasca DR, Lourenco S de QC,. Oral squamous cell carcinoma grading systems-analysis of the best survival predictor. J Oral Pathol Med 2012; 41: 34-39.
10. Sawair FA, Irwin CR, Gordon DJ, Leonard AG, Stephenson M, Napier SS,. Invasive front grading: reliability and usefulness in the management of oral squamous cell carcinoma. J Oral Pathol Med 2003; 32: 1-9.
11. Odell EW, Jani P, Sherriff M, et al. The prognostic value of individual histologic grading parameters in small lingual squamous cell carcinomas. The importance of the pattern of invasion. Cancer 1994; 74: 789-794.
12. Liao C-T, Chang JT-C, Wang H-M, et al. Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol 2008; 15: 915-922.
13. Kurokawa H, Zhang M, Matsumoto S, et al. The high prognostic value of the histologic grade at the deep invasive front of tongue squamous cell carcinoma. J Oral Pathol Med 2005; 34: 329-333.
14. Larsen SR, Johansen J, Sorensen JA, Krogdahl A,. The prognostic significance of histological features in oral squamous cell carcinoma. J Oral Pathol Med 2009; 38: 657-662.
15. Grimm M,. Prognostic value of clinicopathological parameters and outcome in 484 patients with oral squamous cell carcinoma: microvascular invasion (V+) is an independent prognostic factor for OSCC. Clin Transl Oncol 2012; 14: 870-880. doi: 10.1007/s12094-012-0867-2. Epub 2012.
16. Kearsley J, Thomas S,. Prognostic markers in cancers of the head and neck region. Anticancer Drugs 1993; 4: 419-429.
17. Green FL,. AJCC cancer staging manual. 6th ed. New York, NY: Springer-Verlag; 2002.
18. Barnes L, Evenson JW, Reichart P, Sidransky D, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Lyon, France: IARC Press; 2005: 163-208.
19. Abeloff M, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG,. Abeloff's Clinical Oncology. 4th ed. Philadelphia, PA: Churchill Livingstone; 2008.
20. Kademani D, Bell RB, Bagheri S, et al. Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade. J Oral Maxillofac Surg 2005; 63: 1599-1605.
21. National Cancer Institute, US National Institutes of Health, Surveillance Research Program, Cancer Statistics Branch, Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2011 Sub (1973-2009 varying)-Linked To County Attributes-Total U.S., 1969-2010 Counties. Available from: http://www.seer.cancer.gov. Accessed March 2013.
22. Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). Bethesda, MD: National Cancer Institute; 2012.
23. Greene FL, Page DL, Fleming ID, eds. Ajcc Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
24. Fritz A, Jack A, Parkin DM, et al. International Classification of Diseases for Oncology (ICD-O). 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
25. SEER*Stat [computer program]. Version 8.0.2. Bethesda, MD: National Cancer Institute, Surveillance Research Program; 2013.
26. Boysen M, Loven JO,. Second malignant neoplasms in patients with head and neck squamous cell carcinomas. Acta Oncol 1993; 32: 283-288.
27. Chuang S-C, Scelo G, Tonita JM, et al. Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries. Int J Cancer 2008; 123: 2390-2396.
28. Allison PD,. Survival Analysis Using the SAS System A practical Guide. Cary, NC: SAS Publishing; 1998.
29. Funk GF, Karnell LH, Robinson RA, Zhen WK, Trask DK, Hoffman HT,. Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck 2002; 24: 165-180.